This study aims to evaluate the clinical success of complete pulpotomy using Biodentine in mature permanent single-rooted teeth diagnosed with symptomatic irreversible pulpitis. Complete pulpotomy involves removal of the coronal pulp and preservation of radicular pulp vitality using a biocompatible pulp-capping material. Biodentine, a calcium silicate-based cement, has favorable biological properties, including biocompatibility, antibacterial effects, and dentin bridge formation potential. A total of 84 patients meeting the inclusion criteria will be enrolled and treated by a single operator. Clinical success will be evaluated at 7 days, 1 month, and 3 months based on absence of pain, swelling, tenderness to percussion, and radiographic signs of periapical pathology.

Inclusion Criteria:

• Mature permanent single rooted teeth with:

  • Symptomatic irreversible pulpitis
  • Age group 20-50 years

Exclusion Criteria:

• • Uncontrolled pulp heamorrhage (more than 5mins)

  • Necrotic pulp
  • Periapical periodontitis
  • Sinus tract
  • Abnormal tooth mobility
  • Single rooted teeth with internal or external root resorption
  • Calcified root canals